NewsRx

Search our medical news database

Medical News Article on Osteoporosis

New Findings in Osteoporosis Described by S. Papapoulos and Co-Researchers

2012 MAY 10 -- According to the authors of recent research from Detroit, Michigan, "The 3-year FREEDOM trial assessed the efficacy and safety of 60'mg denosumab every 6 months for the treatment of postmenopausal women with osteoporosis. Participants who completed the FREEDOM trial were eligible to enter an extension to continue the evaluation of denosumab efficacy and safety for up to 10 years."

"For the extension results presented here, women from the FREEDOM denosumab group had 2 more years of denosumab treatment (long-term group) and those from the FREEDOM placebo group had 2 years of denosumab exposure (cross-over group). We report results for bone...

In order to view the entire article, please read your options to the right

Purchase this Article

Price: $3.00


NewsRx Customer?

If you have an account with NewsRx and have purchased either a NewsRx Bundled package or a NewsRx Pass, you can log into your account below to access this article.

Email:

Password:

New to NewsRx?

If you are new to NewsRx, you may also take advantage of cost-saving options such as those below to view this article.

Purchase a NewsRx Pass

View an unlimited number of articles for a day, week, month, etc.

Purchase NewsRx Bundled

Purchase a bundle of article-viewing-credits that never expire and receive a discount of up to 50%!

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook